BIOSPECIFICS TECHNOLOGIES CORP Deferred Tax Expense from Stock Options Exercised

BIOSPECIFICS TECHNOLOGIES CORP Deferred Tax Expense from Stock Options Exercised

BIOSPECIFICS TECHNOLOGIES CORP reported Deferred Tax Expense from Stock Options Exercised of $300.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-16.

Discontinued › Cash Flow › Other Cash Flow Items

us-gaap:DeferredTaxExpenseFromStockOptionsExercised · last filed 2017-03-16

• BIOSPECIFICS TECHNOLOGIES CORP deferred tax expense from stock options exercised for fiscal 2016 was $300.00K, a 92.11% decline from fiscal 2015.
• BIOSPECIFICS TECHNOLOGIES CORP deferred tax expense from stock options exercised for fiscal 2015 was $3.80M, a 100.00% increase from fiscal 2014.
• BIOSPECIFICS TECHNOLOGIES CORP deferred tax expense from stock options exercised for fiscal 2014 was $1.90M.